ArticleMolecular therapy : the journal of the American Society of Gene Therapy2024

Blunting specific T-dependent antibody responses with engineered "decoy" B cells.

Ragan A Pitner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.